Cargando…
Transdermal nicotine in non-smokers: A systematic review to design COVID-19 clinical trials
Recent data show an interaction between COVID-19 and nicotine and indicate the need for an assessment of transdermal nicotine use in non-smokers. Assessments have been conducted into the short-term cognitive effects of nicotine and into diseases such as Parkinson's, Tourette syndrome, ADHD or u...
Autores principales: | Dautzenberg, B., Levi, A., Adler, M., Gaillard, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183099/ https://www.ncbi.nlm.nih.gov/pubmed/34153704 http://dx.doi.org/10.1016/j.resmer.2021.100844 |
Ejemplares similares
-
Genetic and Pharmacokinetic Determinants of Response to Transdermal Nicotine in White, Black and Asian Non-Smokers
por: Dempsey, Delia A., et al.
Publicado: (2013) -
Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration
por: Olsson Gisleskog, Per O., et al.
Publicado: (2020) -
Transdermal nicotine replacement is associated with lower mortality among active smokers admitted with spontaneous subarachnoid hemorrhage
por: Seder, D, et al.
Publicado: (2008) -
Is Transdermal Nicotine Associated with Cardiovascular Risk?
por: Thomas, G A O, et al.
Publicado: (1995) -
Comparison of Pectin Layers for Nicotine Transdermal Patch Preparation
por: Suksaeree, Jirapornchai, et al.
Publicado: (2018)